Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.820
-0.240 (-5.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $38.73 million as of December 20, 2024. Its market cap has increased by 77.24% in one year.
Market Cap
38.73M
Enterprise Value
23.56M
1-Year Change
77.24%
Ranking
Category
Stock Price
3.82
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $38.73M, a decrease of -55.58%. That is a compound annual growth rate of -5.98%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapid Micro Biosystems | 43.03M |
| Lucid Diagnostics | 42.74M |
| CollPlant Biotechnologies | 42.10M |
| Gain Therapeutics | 41.64M |
| Xilio Therapeutics | 41.23M |
| Exicure | 41.01M |
| Cardio Diagnostics Holdings | 40.84M |
| ImmuCell | 40.82M |